Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

BackgroundFrailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We sought to assess the effectiveness and safety of apixaban, dabigatran and rivaroxaban versus warfarin in frail nonvalvular atrial fibrillation patients. Methods and Resul...

Description complète

Détails bibliographiques

Auteurs principaux:	Brandon K. Martinez, Nitesh A. Sood, Thomas J. Bunz, Craig I. Coleman
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2018-04-01
Collection:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Sujets:	anticoagulants atrial fibrillation direct‐acting oral anticoagulants frailty warfarin
Accès en ligne:	https://www.ahajournals.org/doi/10.1161/JAHA.118.008643
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!